Literature DB >> 13935902

The reticulo-endothelial system and red cell destruction.

P L MOLLISON.   

Abstract

Keywords:  ERYTHROCYTES; RETICULOENDOTHELIAL SYSTEM

Mesh：

Year:  1962        PMID： 13935902      PMCID： PMC1896945     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  17 in total

1.  Use of isotope-labelled red cells to demonstrate incompatibility in vivo.

Authors:  P L MOLLISON; M CUTBUSH
Journal:  Lancet       Date:  1955-06-25       Impact factor: 79.321

2.  Studies on the survival of incompatible cells in patients with hypogammaglobulinemia.

Authors:  H CHAPLIN
Journal:  Blood       Date:  1959-01       Impact factor: 22.113

3.  The role of the reticulo-endothelial cell in iron metabolism.

Authors:  W D NOYES; T H BOTHWELL; C A FINCH
Journal:  Br J Haematol       Date:  1960-01       Impact factor: 6.998

4.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

5.  Removal of incompatible red cells by the spleen.

Authors:  N C JONES; P L MOLLISON; N VEALL
Journal:  Br J Haematol       Date:  1957-04       Impact factor: 6.998

6.  The relationship of abnormal red cells to the normal spleen.

Authors:  I M HARRIS; J M MCALISTER; T A PRANKERD
Journal:  Clin Sci       Date:  1957-05       Impact factor: 6.124

7.  Phagocytosis of foreign red blood cells by the reticulo-endothelial system.

Authors:  B N HALPERN; G BIOZZI; B BENACERRAF; C STIFFEL
Journal:  Am J Physiol       Date:  1957-06

8.  Relation between characteristics of blood-group antibodies in vitro and associated patterns of redcell destruction in vivo.

Authors:  M CUTBUSH; P L MOLLISON
Journal:  Br J Haematol       Date:  1958-04       Impact factor: 6.998

9.  Use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis.

Authors:  M V WALLER; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

10.  Inhibition of red cell sequestration by cortisone.

Authors:  M E KAPLAN; J H JANDL
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307
View more
  8 in total

1.  Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.

Authors:  J P Atkinson; A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

2.  Studies on hepatic uptake of antigen. I. Comparison of inferior vena cava and portal vein routes of immunization.

Authors:  D R Triger; M H Cynamon; R Wright
Journal:  Immunology       Date:  1973-12       Impact factor: 7.397

3.  An immunological basis for the anaemia of acute Salmonella gallinarum infection of chicken. II. The relationship of the immune response to the development of the haemolytic anaemia.

Authors:  R Assoku; W Penhale
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

4.  [RES-clearance of erythrocytes changed by heat, a new criterion in diseases of the bone marrow].

Authors:  J Fischer; R Wolf
Journal:  Blut       Date:  1967-04

5.  [Elimination of Rh-positive fetal erythrocytes from the blood of rh-negative women by autologous isoagglutinins].

Authors:  W Sieg; P Börner; H U Pixberg; H Deicher
Journal:  Blut       Date:  1970-08

6.  Red cell survival studies in hereditary spherocytosis.

Authors:  J S Wiley
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

7.  Autoimmune haemolytic anaemias. IV. Biochemical studies of red cells from patients with autoimmune haemolytic anaemia with incomplete warm autoantibodies.

Authors:  C P Engelfriet; D Beckers; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

Review 8.  Plasmodium falciparum malaria and invasive bacterial co-infection in young African children: the dysfunctional spleen hypothesis.

Authors:  Gloria P Gómez-Pérez; Robin van Bruggen; Martin P Grobusch; Carlota Dobaño
Journal:  Malar J       Date:  2014-08-26       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.